regulatory B cell gene therapy (Deutsches Rheuma-Forschungs Zentrum Berlin/Ascenion)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Nameregulatory B cell gene therapy (Deutsches Rheuma-Forschungs Zentrum Berlin/Ascenion)
Drug Alias NameB-cell gene therapy (DRFZ/Ascenion)
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionCluster of differentiation 8 inhibitorsT-cell surface antigen CD4 inhibitors
TargetsT-cell surface antigen CD4Cluster of differentiation 8
Therapy Area/IndicationsAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDeutsches Rheuma-Forschungszentrum Berlin
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAscenionDeutsches Rheuma-Forschungszentrum Berlin
Active IndicationsN/A
Inactive IndicationsAutoimmune Diseases

Other Information

ATC CodeN/A
Related LinksN/A